Kelly Durante signed Edenbridge Pharmaceuticals LLC's 2024 Form 5500 as plan administrator.
Signer names are public record from the Form 5500 e-signature.
Edenbridge Pharmaceuticals LLC's EIN is 26-1870197.
Download the official 2024 Form 5500 (PDF) for Edenbridge Pharmaceuticals LLC from the U.S. Department of Labor's EFAST2 system.
Download the official 2024 Form 5500 (PDF)Edenbridge Pharmaceuticals LLC's plan includes profit-sharing, ERISA 404(c) participant direction, a 401(k) feature, automatic enrollment, a default investment (QDIA).